RedHill Biopharma (NASDAQ:RDHL) Earns Hold Rating from Analysts at StockNews.com
Stock analysts at StockNews.com initiated coverage on shares of RedHill Biopharma (NASDAQ:RDHL – Get Free Report) in a research report issued to clients and investors on Friday. The firm set a “hold” rating on the biotechnology company’s stock. RedHill Biopharma Price Performance RedHill Biopharma stock opened at $1.81 on Friday. The company’s 50-day moving average […]
Stock analysts at StockNews.com initiated coverage on shares of RedHill Biopharma (NASDAQ:RDHL – Get Free Report) in a research report issued to clients and investors on Friday. The firm set a “hold” rating on the biotechnology company’s stock. RedHill Biopharma Price Performance RedHill Biopharma stock opened at $1.81 on Friday. The company’s 50-day moving average […]
